OIA
ALIM

Optimum Investment Advisors’s Alimera Sciences ALIM Stock Holding History

Optimum Investment Advisors’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,108
Closed -$22K – 904
2022
Q2 		$22K Sell
4,108
-4,000
-49% -$22K 0.01% 504
2022
Q1 		$45K Hold
8,108
– – 0.02% 456
2021
Q4 		$42K Hold
8,108
– – 0.02% 496
2021
Q3 		$34K Buy
8,108
+5,108
+170% +$35.6K 0.01% 526
2021
Q2 		$27K Buy
+3,000
New +$29.5K 0.01% 619

Other funds holding ALIM

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Optimum Investment Advisors's ALIM Position: Q3 2022 in Review

Optimum Investment Advisors sold out of Alimera Sciences (ALIM) in Q3 2022, closing a stake of 4,108 shares — an estimated $22K sold.

Optimum Investment Advisors first reported a position in ALIM in Q2 2021 and held it in 5 quarters. The position peaked at $45K in Q1 2022. 14 funds tracked by Wall St. Rank hold ALIM as of Q3 2022.

  • Optimum Investment Advisors reported no remaining Alimera Sciences position as of Q3 2022 after selling out during the quarter.
  • Optimum Investment Advisors sold 4,108 Alimera Sciences shares in Q3 2022, an estimated $22K.
  • Optimum Investment Advisors first reported a position in Alimera Sciences in Q2 2021 and held it in 5 quarters.
  • Optimum Investment Advisors's Alimera Sciences position peaked at $45K in Q1 2022.
  • 14 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2022.

Based on Optimum Investment Advisors's 13F filing for Q3 2022, filed 24 Oct 2022.